Вы находитесь на странице: 1из 1

Federal Register / Vol. 71, No.

188 / Thursday, September 28, 2006 / Notices 56993

ESO–1/CAG–3-specific T cells to elicit DEPARTMENT OF HEALTH AND Scientific Review, National Center for
an anti-cancer immunogenic response HUMAN SERVICES Complementary and Alternative Medicine,
and thereby eliminating or reducing the NIH, 6707 Democracy Blvd., Suite 401,
National Institutes of Health Bethesda, MD 20892, (301) 594–9096,
cancer. While these vaccines and jeanetteh@mail.nih.gov.
pharmaceutical compositions may be Name of Committee: National Center for
National Center for Complementary &
developed for use against a variety of Complementary and Alternative Medicine
Alternative Medicine; Notice of Closed
cancers, data obtained to date indicate Special Emphasis Panel; Developmental
Meetings
that they may be of particular value for Centers for Research on CAM.
use against melanoma. Pursuant to section 10(d) of the Date: November 16–17, 2006.
Federal Advisory Committee Act, as Time: 8 a.m. to 5 p.m.
Methods for diagnosing cancer via the Agenda: To review and evaluate grant
detection of NY ESO–1/CAG–3 are also amended (5 U.S.C. Appendix 2), notice
applications.
embodied in the invention. is hereby given of the following Place: Bethesda, Marriott, 5151 Pooks Hill
meetings. Road, Bethesda, MD 20814.
Inventors: Steven A. Rosenberg (NCI) The meetings will be closed to the Contact Person: Martina Schmidt, PhD,
et al. public in accordance with the Scientific Review Administrator, Office of
Patent Status: U.S. Patent No. provisions set forth in sections Scientific Review, National Center for
7,084,239 issued 01 Aug 2006 (HHS 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Complementary and Alternative Medicine,
as amended. The grant applications and NIH, 6707 Democracy Blvd., Suite 401,
Reference No. E–265–1997/0–US–04). Bethesda, MD 20892, (301) 594–3456,
the discussions could disclose
Licensing Status: Available for non- schmidma@mail.nih.gov.
confidential trade secrets or commercial
exclusive licensing or exclusive property such as patentable material,
licensing. Dated: September 19, 2006.
and personal information concerning Anna Snouffer,
Licensing Contact: Jesse S. Kindra, individuals associated with the grant Acting Director, Office of Federal Advisory
J.D.; 301/435–5559; application, the disclosure of which Committee Policy.
kindraj@mail.nih.gov. would constitute a clearly unwarranted [FR Doc. 06–8328 Filed 9–27–06; 8:45 am]
Dated: September 20, 2006. invasion of personal privacy.
BILLING CODE 4140–01–M
Steven M. Ferguson, Name of Committee: National Center for
Complementary and Alternative Medicine
Director, Division of Technology Development Special Emphasis Panel; Basic Science.
and Transfer, Office of Technology Transfer, DEPARTMENT OF HEALTH AND
Date: October 23–24, 2006. HUMAN SERVICES
National Institutes of Health. Time: 8 a.m. to 4 p.m.
[FR Doc. E6–15975 Filed 9–27–06; 8:45 am] Agenda: To review and evaluate grant National Institutes of Health
BILLING CODE 4140–01–P applications.
Place: Bethesda Marriott Suites, 6711 National Institute of Allergy and
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Dale L. Birkle, PhD,
Infectious Diseases; Notice of Closed
DEPARTMENT OF HEALTH AND Scientific Review Administrator, Office of Meetings
HUMAN SERVICES Scientific Review, National Center for Pursuant to section 10(d) of the
Complementary and Alternative Medicine,
National Institutes of Health Federal Advisory Committee Act, as
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 451–6570, amended (5 U.S.C. Appendix 2), notice
Clinical Center; Amended Notice of birkled@mail.nih.gov. is hereby given of the following
Meeting Name of Committee: National Center for meetings.
Complementary and Alternative Medicine The meetings will be closed to the
Notice is hereby given of a change in Special Emphasis Panel; Clinical Research. public in accordance with the
the meeting of the NIH Advisory Board Date: October 30–31, 2006. provisions set forth in sections
for Clinical Research, September 29, Time: 8 a.m. to 5 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
2006, 10 a.m. to September 29, 2006, 2 Agenda: To review and evaluate grant as amended. The contract proposals and
p.m. National Institutes of Health, applications. discussions could disclose confidential
Place: Embassy Suites at the Chevy Chase trade secrets or commercial property
Building 10, 10 Center Drive, 4–2551, Pavilion, 4300 Military Road, NW.,
CRC Medical Board Room, Bethesda, such as patentable material, and
Washington, DC 20015.
MD 20892 which was published in the personal information concerning
Contact Person: Jeanette M. Hosseini, PhD,
Federal Register on September 8, 2006, Scientific Review Administrator, Office of individuals associated with the contract
FR 06–7534. Scientific Review, National Center for proposals, the disclosure of which
Complementary and Alternative Medicine, wouldconstitute a clearly unwarranted
The open session will occur from 10 NIH, 6707 Democracy Blvd., Suite 401, invasion of personal privacy.
a.m.–1:30 p.m. The closed session will Bethesda, MD 20892, (301) 594–9096, Name of Committee: National Institute of
begin approximately at 1:30 p.m. and jeanetteh@mail.nih.gov. Allergy and Infectious Diseases Special
run until 2 p.m. The meeting will be Name of Committee: National Center for Emphasis Panel; Tropical Medicine Research
held in the Clinical Center, Bldg. 10, Complementary and Alternative Medicine Centers.
Rm. 4–2551, CRC Medical Board Room. Special Emphasis Panel; Clinical Research Date: October 16–18, 2006.
The meeting is partially Closed to the Huntington’s Disease. Time: 8 a.m. to 12 p.m.
public. Date: October 31, 2006. Agenda: To review and evaluate grant
Time: 1 p.m. to 5 p.m. applications.
Dated: September 19, 2006. Agenda: To review and evaluate grant Place: Hyatt Regency Bethesda, One
sroberts on PROD1PC70 with NOTICES

Anna Snouffer, applications. Bethesda Metro Center, 7400 Wisconsin


Acting Director, Office of Federal Advisory Place: Embassy Suites at the Chevy Chase Avenue, Bethesda, MD 20814.
Pavilion, 4300 Military Road, NW., Contact Person: Gary S. Madonna, PhD,
Committee Policy.
Washington, DC 20015. Scientific Review Administrator, Scientific
[FR Doc. 06–8329 Filed 9–27–06; 8:45 am] Contact Person: Jeanette M. Hosseini, PhD, Review Program, Division of Extramural
BILLING CODE 4140–01–M Scientific Review Administrator, Office of Activities, National Institutes of Health/

VerDate Aug<31>2005 20:16 Sep 27, 2006 Jkt 208001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM 28SEN1

Вам также может понравиться